Mylan N.V. (MYL) Financial Statements (2023 and earlier)

Company Profile

Business Address BUILDING 4, TRIDENT PLACE, MOSQUITO WAY
HATFIELD, HERTFORDSHIRE, AL10 9UL
State of Incorp.
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in millions)

9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments665324572 359212230
Cash and cash equivalents665324572 359212230
Restricted cash and investments3116 1611
Receivables2,5882,4412,429 2,5472,2772,367
Inventory, net of allowances, customer advances and progress billings3,0222,7862,640 2,7642,7762,709
Inventory3,0222,7862,640 2,7642,7762,709
Prepaid expense189168162 154154132
Other current assets361336311 284301311
Other undisclosed current assets507409471 523545513
Total current assets:7,3356,4656,601 6,6456,2656,262
Noncurrent Assets
Property, plant and equipment2,0582,0382,067 2,1242,1462,151
Intangible assets, net (including goodwill)20,78320,47920,374 21,21122,42422,563
Goodwill9,8179,5239,327 9,3879,6939,608
Intangible assets, net (excluding goodwill)10,96610,95611,047 11,82412,73112,956
Regulated entity, other noncurrent assets  57    
Deferred income tax assets658749     
Other noncurrent assets409425404 445429422
Deferred tax assets, net628553508
Other undisclosed noncurrent assets  645    
Total noncurrent assets:23,90823,69123,545 24,40825,55225,644
TOTAL ASSETS:31,24330,15530,146 31,05431,81731,907
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1,7911,5451,528 1,6651,6771,340
Taxes payable343288254 15313923
Accounts payable1,4481,2571,274 1,5111,5381,317
Other liabilities2,2462,2282,213 2,3752,1332,114
Other undisclosed current liabilities3,2383,1981,488 605751704
Total current liabilities:7,2756,9715,228 4,6454,5604,158
Noncurrent Liabilities
Long-term debt and lease obligation9,2589,15411,198 12,46112,59013,087
Long-term debt, excluding current maturities9,1028,99411,198 12,46112,59013,087
Liabilities, other than long-term debt, including:938882 84254237
Deferred tax liabilities, net1,5571,6351,643
Deferred income tax liabilities1,4171,542     
Liability for uncertainty in income taxes137110101 756476
Liability, pension and other postretirement and postemployment benefits412402406 383393390
Other liabilities901901919 9281,1291,127
Operating lease, liability157159     
Other undisclosed liabilities, other than long-term debt(2,775)(2,868)(1,343) (2,859)(2,968)(3,000)
Other undisclosed noncurrent liabilities2,0692,1972,375 2,4012,5102,534
Total noncurrent liabilities:11,42011,43813,655 14,94515,35415,857
Total liabilities:18,69518,40918,883 19,59019,91420,015
Equity
Equity, attributable to parent12,54811,74611,263 11,463(2,402)(2,598)
Common stock666 6  
Treasury stock, value(1,000)(1,000)(1,000) (1,000)(1,000)(1,000)
Additional paid in capital8,6888,6738,658 8,638  
Accumulated other comprehensive loss(1,424)(2,025)(2,454) (2,191)(1,402)(1,599)
Retained earnings6,2776,0926,052 6,011  
Other undisclosed equity     14,30414,490
Total equity:12,54811,74611,263 11,46311,90311,892
TOTAL LIABILITIES AND EQUITY:31,24330,15530,146 31,05431,81731,907

Income Statement (P&L) ($ in millions)

9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
Revenues2,9722,7312,619(8,309)2,9622,8522,496
Cost of revenue
(Cost of Goods and Services Sold)
(1,814)(1,706)(1,713) (1,889)(1,919)(1,690)
Gross profit:1,1591,026906 1,072933805
Operating expenses(807)(892)(721) (749)(837)(781)
Operating income:351134185 3249624
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
82(34) (9)(16)(7)
Interest and debt expense(117)(116)(120) (129)(131)(131)
Income (loss) from continuing operations before income taxes:2422031 186(52)(115)
Income tax expense (benefit)(56)19(10) 4(116)90
Income (loss) from continuing operations:1863921 190(169)(25)
Income (loss) before gain (loss) on sale of properties:1863921 190(169)(25)
Net income (loss) available to common stockholders, diluted:1863921 190(169)(25)

Comprehensive Income ($ in millions)

9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
Net income (loss):1863921 190(169)(25)
Other comprehensive income (loss)601429(656) (650)169(266)
Comprehensive income (loss), net of tax, attributable to parent:787468(636) (460)0(291)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: